- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06337123
Physica TT Tibial Plate Follow up Study
A Post Market Clinical Study Evaluating Clinical and Radiographic Outcomes of Total Knee Arthroplasty With Physica Porous KR or Physica Porous PS in Combination With Physica TT Tibial Plate in Cementless Configuration.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Domizia Baldassi
- Phone Number: +39 3357492586
- Email: domizia.baldassi@limacorporate.com
Study Contact Backup
- Name: Federica Azzimonti
- Phone Number: +39 3775450940
- Email: federica.azzimonti@limacorporate.com
Study Locations
-
-
-
Messina, Italy, 98100
- Casa di Cura Carmona
-
Contact:
- Marcello La Bruna
-
Principal Investigator:
- Marcello La Bruna
-
Perugia, Italy, 06100
- Istituto Clinico Porta Sole
-
-
Lucca
-
Forte Dei Marmi, Lucca, Italy, 55042
- Casa di Cura San Camillo Hopital
-
Contact:
- Alessandro Tripodo
-
Principal Investigator:
- Alessandro Tripodo
-
-
Rimini
-
Torre Pedrera, Rimini, Italy, 47922
- Ospedale Privato Accreditato Sol et Salus
-
Contact:
- Marco Fravisini
-
Principal Investigator:
- Marco Fravisini
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female of any race requiring a total knee replacement (TKR) and suitable for receiving Physica Porous KR or Physica Porous PS femoral component in combination with Physica TT Tibial Plate.
- Age ≥ 18 years old.
Candidate for primary total knee replacement when clinical indications based on physical examination and medical history include one or more of the following conditions:
- Non-inflammatory degenerative joint disease like knee osteoarthritis, post traumatic knee arthritis
- Inflammatory degenerative joint disease like rheumatoid arthritis
- Any other medical reason for which the investigator deems the subject as a possible candidate for total knee replacement.
Patient has well-preserved and well-functioning collateral ligaments and one of the following conditions:
- Absent or not-functioning posterior cruciate ligament and severe antero-posterior instability of the knee joint (for Physica Porous PS)
- Undamaged and functional posterior cruciate ligament (for Physica Porous KR)
- Patient is able to understand the conditions of the study, to comply with the prescribed rehabilitation as well as willing to perform all scheduled follow-up visits.
- Patient signed the study-specific informed consent form approved by the ethics committee before study activities
Exclusion Criteria:
- Severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function. Only for Physica Porous KR: important joint instability and deficiency of posterior cruciate ligament.
- Any active or suspected infection (local or systemic) or previous history of infection that may affect the prosthetic joint.
- Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy.
- Significant bone loss on femoral or tibial joint side.
- Affected by malignant cancer with life expectancy less than 2 years or where cancer treatment might affect the normal postoperative course.
- Known incompatibility or allergy to the product materials, and/or metal hypersensitivity to implant materials.
- Septicaemia.
- Persistent acute or chronic osteomyelitis.
- Open epiphyses (immature patient with active bone growth).
- Necrotic bone
- Arterial vascular insufficiency or nerve diseases of the lower limbs severe enough to interfere with the study evaluation.
- Compromised bone stock due to disease, infection or prior implantation that cannot provide adequate support and/or fixation to the prosthesis.
- Systemic or metabolic disorders leading to progressive bone deterioration, which may impair fixation and stability of the implant.
- Any concomitant disease and dependency that might affect the performance of the implanted prosthesis.
- Any clinically major pathology based on clinical medical history or any medical intervention or reason that the Investigator feels may affect the study evaluation.
- Neurological or musculoskeletal disorder or disease that may adversely affect gait, functional recovery and evaluation.
- Neuromuscular or neurosensory deficit that would hamper the performance assessment of the device.
- Any psychiatric illness that would prevent comprehension of the details and nature of the study.
- Simultaneously taking part in another surgical intervention study or pain management study that may affect with clinical study outcomes.
- Female patient who is pregnant, nursing, or planning a pregnancy.
- Important osteoporosis, haemophilic disease.
- Internistic problems with high risk for surgery.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Physica Porous KR femoral component
Devices: Physica TT Tibial Plate and Physica Porous KR femoral component Total knee arthroplasty with Physica TT Tibial Plate and Physica Porous KR femoral component |
Devices: Physica TT Tibial Plate and Physica Porous KR femoral component Data collection of population that underwent total knee arthroplasty with Physica TT Tibial Plate and Physica Porous KR femoral component |
Physica Porous PS femoral component
Devices: Physica TT Tibial Plate and Physica Porous PS femoral component Total knee arthroplasty with Physica TT Tibial Plate and physica Porous PS femoral component |
Devices: Physica TT Tibial Plate and Physica Porous KR femoral component Data collection of population that underwent total knee arthroplasty with Physica TT Tibial Plate and Physica Porous PS femoral component |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Knee Society Score (KSS) equal or greater than "Good" (score ≥ 70) 2 years after surgery
Time Frame: 2 years after surgery
|
0-100 scale.
Scores rating from 80 to 100 are considered excellent, between 70 and 79 good, between 60 and 69 fair, and less than 60 poor
|
2 years after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Range of Motion over time up to 2 years after surgery
Time Frame: From preoperative to 2 years after surgery
|
From preoperative to 2 years after surgery
|
|
Changes in Oxford Knee Score (OKS) over time up to 2 years after surgery.
Time Frame: From preoperative to 2 years after surgery
|
Overall score from 0 to 48, with 48 being the best outcome
|
From preoperative to 2 years after surgery
|
Changes in Forgotten Joint Score (FJS) over time up to 2 years after surgery.
Time Frame: From preoperative to 2 years after surgery
|
Overall score from 0 to 100, with 100 being the best outcome
|
From preoperative to 2 years after surgery
|
Changes in Visual Analogue Scale (VAS) Pain over time up to 2 years after surgery.
Time Frame: From preoperative to 2 years after surgery
|
100 mm line, with 0 mm being best outcome (no pain) and 100 mm worst outcome (very severe pain)
|
From preoperative to 2 years after surgery
|
Radiographic implant evaluation and stability assessment from postoperative (baseline) over time up to 2 years after surgery
Time Frame: From preoperative to 2 years after surgery
|
The treated knee is analyzed postoperatively based on anteroposterior and lateral x-rays view of the knee. The following parametner are evaluated:
|
From preoperative to 2 years after surgery
|
Survival rate (Kaplan-Meier) at 2 years after surgery
Time Frame: From preoperative to 2 years after surgery
|
From preoperative to 2 years after surgery
|
|
Incidence, type and severity of Adverse Device Effects (ADE) and Serious Adverse Device Effects (SADE) up to 2 years follow up
Time Frame: From preoperative to 2 years after surgery
|
From preoperative to 2 years after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alessandro Tripodo, Casa di Cura San Camillo Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K-38
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Arthropathy
-
Xiangya Hospital of Central South UniversityActive, not recruitingKnee Arthropathy | Hip Arthropathy | Ankle Arthropathy | Elbow Arthropathy | Shoulder ArthropathyChina
-
IRCCS San Raffaele RomaCompletedTotal Knee Replacement | Knee ArthropathyItaly
-
Stryker OrthopaedicsRecruitingKnee Arthritis | Arthropathy of Knee | ReplacementUnited States
-
The Catholic University of KoreaUnknownKnee Arthropathy | Anatomically Aligned Total Knee Arthroplasty
-
Total Sports Medicine & OrthopedicsIncrediwear Holdings IncNot yet recruitingKnee Arthroscopy | Knee Arthropathy Associated With Other Conditions
-
Universidad de ZaragozaCompletedArthropathy of Knee | Arthropathy of HipSpain
-
Centre Hospitalier Universitaire de la RéunionCompletedArthropathy of Knee | Arthropathy of HipRéunion
-
Super Inspired LLCRecruitingArthropathy of Knee | Arthropathy of HipUnited States
-
Medical University of South CarolinaCompletedArthropathy of Knee | Arthropathy of HipUnited States
-
Hvidovre University HospitalCompletedArthropathy of Knee | Arthropathy of HipDenmark